Is there any guidance or regulation that present the regulator's considerations on reference listed drug lots selection in generic drug development? Is it appropriate to use different RLD lots in generic drug stability testing or in dissolution comparison? And if we find quality differences between different RLD lot, what should we do?
Topic: RLD lots used in generic drug development26 January 2015 Last edited: 26 January 2015 At 6:35pm
Have an insight or suggestion?
Login or register to post a comment.